• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2016年至2017年中国内地出现的人感染高致病性禽流感A(H7N9)病毒的生物学特征

Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017.

作者信息

Zhu Wenfei, Zhou Jianfang, Li Zi, Yang Lei, Li Xiyan, Huang Weijuan, Zou Sumei, Chen Wenbing, Wei Hejiang, Tang Jing, Liu Liqi, Dong Jie, Wang Dayan, Shu Yuelong

机构信息

National Institute for Viral Disease Control and Prevention, China Centers for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China.

These authors contributed equally to this work.

出版信息

Euro Surveill. 2017 May 11;22(19). doi: 10.2807/1560-7917.ES.2017.22.19.30533.

DOI:10.2807/1560-7917.ES.2017.22.19.30533
PMID:28537546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5476987/
Abstract

With no or low virulence in poultry, avian influenza A(H7N9) virus has caused severe infections in humans. In the current fifth epidemic wave, a highly pathogenic avian influenza (HPAI) H7N9 virus emerged. The insertion of four amino acids (KRTA) at the haemagglutinin (HA) cleavage site enabled trypsin-independent infectivity of this virus. Although maintaining dual receptor-binding preference, its HA antigenicity was distinct from low-pathogenic avian influenza A(H7N9). The neuraminidase substitution R292K conferred a multidrug resistance phenotype.

摘要

甲型H7N9禽流感病毒在家禽中致病性无或低,但却在人类中引发了严重感染。在当前的第五波疫情中,出现了一种高致病性禽流感(HPAI)H7N9病毒。血凝素(HA)裂解位点插入的四个氨基酸(KRTA)使该病毒具有不依赖胰蛋白酶的感染性。尽管保持了对两种受体的结合偏好,但其HA抗原性与低致病性甲型H7N9禽流感不同。神经氨酸酶的R292K替换赋予了多重耐药表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d017/5476987/5acd4a8b549c/eurosurv-22-30533-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d017/5476987/336e61663865/eurosurv-22-30533-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d017/5476987/5acd4a8b549c/eurosurv-22-30533-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d017/5476987/336e61663865/eurosurv-22-30533-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d017/5476987/5acd4a8b549c/eurosurv-22-30533-f2.jpg

相似文献

1
Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017.2016年至2017年中国内地出现的人感染高致病性禽流感A(H7N9)病毒的生物学特征
Euro Surveill. 2017 May 11;22(19). doi: 10.2807/1560-7917.ES.2017.22.19.30533.
2
Genesis and Spread of Newly Emerged Highly Pathogenic H7N9 Avian Viruses in Mainland China.中国大陆新出现的高致病性H7N9禽流感病毒的起源与传播
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01277-17. Print 2017 Dec 1.
3
Profile and generation of reduced neuraminidase inhibitor susceptibility in highly pathogenic avian influenza H7N9 virus from human cases in Mainland of China, 2016-2019.2016-2019 年中国大陆人感染高致病性禽流感 H7N9 病毒中神经氨酸酶抑制剂耐药性降低的特征和产生。
Virology. 2020 Oct;549:77-84. doi: 10.1016/j.virol.2020.07.018. Epub 2020 Aug 8.
4
The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, 2019.中国大陆 2019 年人感染高致病性禽流感 H7N9 病毒的再现。
Euro Surveill. 2019 May;24(21). doi: 10.2807/1560-7917.ES.2019.24.21.1900273.
5
Phylogenetic and genetic characterization of a 2017 clinical isolate of H7N9 virus in Guangzhou, China during the fifth epidemic wave.中国广州第五波疫情期间 2017 年 H7N9 病毒临床分离株的系统发育和遗传特征
Sci China Life Sci. 2017 Dec;60(12):1331-1339. doi: 10.1007/s11427-017-9152-1. Epub 2017 Oct 9.
6
Did the Highly Pathogenic Avian Influenza A(H7N9) Viruses Emerged in China Raise Increased Threat to Public Health?在中国出现的高致病性甲型流感病毒(H7N9)对公众健康构成了更大威胁吗?
Vector Borne Zoonotic Dis. 2019 Jan;19(1):22-25. doi: 10.1089/vbz.2018.2299. Epub 2018 Sep 15.
7
Co-circulation of multiple genotypes of influenza A (H7N9) viruses in eastern China, 2016-2017.2016 - 2017年中国东部甲型H7N9流感病毒多种基因型的共同流行
Arch Virol. 2018 Jul;163(7):1779-1793. doi: 10.1007/s00705-018-3800-3. Epub 2018 Mar 14.
8
Two Outbreak Sources of Influenza A (H7N9) Viruses Have Been Established in China.中国已确定甲型H7N9流感病毒的两个暴发源头。
J Virol. 2016 May 27;90(12):5561-5573. doi: 10.1128/JVI.03173-15. Print 2016 Jun 15.
9
New Threats from H7N9 Influenza Virus: Spread and Evolution of High- and Low-Pathogenicity Variants with High Genomic Diversity in Wave Five.H7N9 流感病毒的新威胁:第五波高致病性和低致病性变体在高基因组多样性下的传播和演变。
J Virol. 2018 May 14;92(11). doi: 10.1128/JVI.00301-18. Print 2018 Jun 1.
10
The Effects of Genetic Variation on H7N9 Avian Influenza Virus Pathogenicity.遗传变异对 H7N9 禽流感病毒致病性的影响。
Viruses. 2020 Oct 28;12(11):1220. doi: 10.3390/v12111220.

引用本文的文献

1
Attenuation of A(H7N9) influenza virus infection in mice exposed to cigarette smoke.香烟烟雾暴露小鼠中A(H7N9)流感病毒感染的减弱
Npj Viruses. 2024 Mar 25;2(1):16. doi: 10.1038/s44298-024-00026-4.
2
Phylogenetic analyses of the spread of Clade I MPOX in African and non-African nations.非洲和非非洲国家中I类猴痘病毒传播的系统发育分析。
Virus Genes. 2025 Jun;61(3):265-276. doi: 10.1007/s11262-025-02138-2. Epub 2025 Feb 12.
3
Influenza A Virus H7 nanobody recognizes a conserved immunodominant epitope on hemagglutinin head and confers heterosubtypic protection.

本文引用的文献

1
Role of Neuraminidase in Influenza A(H7N9) Virus Receptor Binding.神经氨酸酶在甲型H7N9流感病毒受体结合中的作用
J Virol. 2017 May 12;91(11). doi: 10.1128/JVI.02293-16. Print 2017 Jun 1.
2
Continuing challenges in influenza.流感持续面临的挑战。
Ann N Y Acad Sci. 2014 Sep;1323(1):115-39. doi: 10.1111/nyas.12462. Epub 2014 May 30.
3
Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria.2011-2012 年美国流行的流感病毒的药物敏感性监测:世卫组织抗病毒工作组标准的应用。
甲型流感病毒H7纳米抗体识别血凝素头部保守的免疫显性表位并提供异源亚型保护。
Nat Commun. 2025 Jan 9;16(1):432. doi: 10.1038/s41467-024-55193-y.
4
R229I substitution from oseltamivir induction in HA1 region significantly increased the fitness of a H7N9 virus bearing NA 292K.在血凝素(HA)1 区域的奥司他韦诱导下,R229I 取代显著增加了具有神经氨酸酶(NA)292K 的 H7N9 病毒的适应性。
Emerg Microbes Infect. 2024 Dec;13(1):2373314. doi: 10.1080/22221751.2024.2373314. Epub 2024 Jul 16.
5
Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head.人源中和抗体靶向 H7N9 血凝素头部的一个保守侧部斑块。
Nat Commun. 2024 May 27;15(1):4505. doi: 10.1038/s41467-024-48758-4.
6
Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site.人类 H3N2 流感病毒受体特异性的演变大大扩展了受体结合域位点。
Cell Host Microbe. 2024 Feb 14;32(2):261-275.e4. doi: 10.1016/j.chom.2024.01.003. Epub 2024 Feb 1.
7
Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults.含或不含 AS03 佐剂的不同剂量第五波流感 A/H7N9 灭活疫苗在健康成年人中的免疫原性和安全性。
Vaccine. 2024 Jan 12;42(2):295-309. doi: 10.1016/j.vaccine.2023.12.001. Epub 2023 Dec 16.
8
Allosteric Neutralization by Human H7N9 Antibodies.人源H7N9抗体的变构中和作用
Res Sq. 2023 Nov 7:rs.3.rs-3429355. doi: 10.21203/rs.3.rs-3429355/v1.
9
A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine.TLR9 激动剂与 Alum 佐剂 H7N9 灭活全病毒疫苗协同增强保护性免疫。
Emerg Microbes Infect. 2023 Dec;12(2):2249130. doi: 10.1080/22221751.2023.2249130.
10
Genetic characterization and pathogenicity of H7N9 highly pathogenic avian influenza viruses isolated from South China in 2017.2017年从中国南方分离出的H7N9高致病性禽流感病毒的基因特征及致病性
Front Microbiol. 2023 Mar 7;14:1105529. doi: 10.3389/fmicb.2023.1105529. eCollection 2023.
Influenza Other Respir Viruses. 2014 Mar;8(2):258-65. doi: 10.1111/irv.12215. Epub 2013 Dec 2.
4
Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses.人感染 H7N9 流感病毒血凝素的结构和受体结合特性。
Science. 2013 Oct 11;342(6155):243-7. doi: 10.1126/science.1242917. Epub 2013 Sep 5.
5
Biological features of novel avian influenza A (H7N9) virus.新型甲型 H7N9 禽流感病毒的生物学特征。
Nature. 2013 Jul 25;499(7459):500-3. doi: 10.1038/nature12379. Epub 2013 Jul 3.
6
Human infection with a novel avian-origin influenza A (H7N9) virus.人感染新型甲型 H7N9 流感病毒。
N Engl J Med. 2013 May 16;368(20):1888-97. doi: 10.1056/NEJMoa1304459. Epub 2013 Apr 11.
7
Glycomic analysis of human respiratory tract tissues and correlation with influenza virus infection.人类呼吸道组织的糖组学分析及其与流感病毒感染的相关性。
PLoS Pathog. 2013 Mar;9(3):e1003223. doi: 10.1371/journal.ppat.1003223. Epub 2013 Mar 14.
8
Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray.通过碳水化合物微阵列测定2009年甲型H1N1大流行性流感病毒的受体结合特异性
Nat Biotechnol. 2009 Sep;27(9):797-9. doi: 10.1038/nbt0909-797.
9
In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses.甲型(H5N1)流感病毒神经氨酸酶抑制剂耐药性的体外产生
Antimicrob Agents Chemother. 2009 Oct;53(10):4433-40. doi: 10.1128/AAC.00334-09. Epub 2009 Aug 3.
10
Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin.聚糖拓扑结构决定了人类对禽流感H5N1病毒血凝素的适应性。
Nat Biotechnol. 2008 Jan;26(1):107-13. doi: 10.1038/nbt1375. Epub 2008 Jan 6.